NASDAQ: RGEN
Repligen Corp Stock Ownership - Who owns Repligen?

Insider buying vs selling

Have Repligen Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Karen A. DawesDirector2025-12-17275$161.00
$44.28kSell
Glenn P. MuirDirector2025-12-163,366$26.12
$87.92kBuy
Olivier LoeillotChief Executive Officer2025-11-257,041$170.00
$1.20MSell
James BylundChief Operating Officer2025-11-182,191$151.21
$331.30kSell
Anthony HuntDirector2025-11-132,500$154.32
$385.80kSell
Anthony HuntDirector2025-11-133,000$155.45
$466.35kSell
Anthony HuntDirector2025-11-135,737$156.22
$896.23kSell
Anthony HuntDirector2025-11-132,952$33.87
$99.98kBuy
Anthony HuntDirector2025-11-131,956$157.11
$307.31kSell
Anthony HuntDirector2025-11-131,784$151.01
$269.40kSell

1 of 6

RGEN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RGEN insiders and whales buy or sell their stock.

RGEN Shareholders

What type of owners hold Repligen Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Partners L P19.65%11,060,200$1.54BInsider
Roy T. Eddleman13.65%7,685,810$1.07BInsider
Blackrock Inc10.91%6,139,730$855.88MInstitution
Vanguard Group Inc8.96%5,044,191$703.16MInstitution
Price T Rowe Associates Inc6.23%3,507,378$488.93MInstitution
United Capital Financial Advisors LLC4.90%2,755,943$384.18MInstitution
Fmr LLC4.78%2,691,212$375.15MInstitution
State Street Corp3.20%1,801,536$251.13MInstitution
Citadel Advisors LLC2.99%1,684,720$234.85MInstitution
Point72 Asset Management LP2.56%1,440,721$200.84MInstitution

1 of 3

RGEN vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RGEN74.10%25.90%Net SellingNet Selling
ATR93.89%3.86%Net SellingNet Selling
BLCO10.88%88.47%Net SellingNet Buying
NVST63.78%36.22%Net SellingNet Buying
MMSI94.98%5.02%Net SellingNet Selling

Repligen Stock Ownership FAQ

Who owns Repligen?

Repligen (NASDAQ: RGEN) is owned by 106.94% institutional shareholders, 37.38% Repligen insiders, and 0.00% retail investors. Bvf Partners L P is the largest individual Repligen shareholder, owning 11.06M shares representing 19.65% of the company. Bvf Partners L P's Repligen shares are currently valued at $1.54B.

If you're new to stock investing, here's how to buy Repligen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.